AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Observatory on Cow's Milk Protein Allergy

Recruitingn/aAges any - 8 MonthsAllNutricia Nutrition Clinique
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to describe the symptoms and their evolution up to the age of 5 years in a population of newly diagnosed infants with a suspected or confirmed allergy to cow proteins, for whom the doctor prescribed the Pepticate® Syneo® replacement formula as soon as they were diagnosed. The Pepticate® Syneo® product is an advanced protein hydrolyzate, food type intended for special medical purposes. This is a product already available on the market.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Infants up to and including 8 months (up to 8 months and 29 days). * Initial diagnosis of allergy to cow proteins, suspected (clinical presumption) or confirmed. * Prescription of the substitution formula Pepticate® Syneo, according to the doctor's judgement, whether the child is under mixed or weaned breastfeeding. * Authorisation from a legal representative for the child to take part in the observatory and to collect personal information about the child and the family. * Membership of the social security system. Exclusion Criteria: * Infants who have already received partial or total replacement infant formula (regardless of the type of infant formula). * Contraindication to the use of symbiotics (short small intestine, parenteral nutrition, post-pyloric feeding, central venous catheter) due to the use of Pepticate® Syneo®. * Diagnosis of severe cow protein allergy requiring an infant amino acid formula from the outset. * The child's legal guardian is protected (under legal protection, or deprived of liberty by judicial or administrative decision). * The legal representative is unable to understand the study protocol.
💊

What it tests

  • Pepticate® Syneo®
📍

Where

2 sites
Cabinet du Dr Phu My TRAN
Nice, France
Hôpital Trousseau - APHP
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy